PR - New York Awards Medicaid Fraud Contract to MAXIMUS

MAXIMUS (NYSE: MMS), a leading provider of government consulting services, announced today that it has been awarded a five-year contract with the State of New York, Office of Medicaid Inspector General to provide Medicaid Fraud, Waste, and Abuse Recovery and Retention consulting services.

MAXIMUS will work as a strategic partner with the newly-formed New York State Office of Medicaid Inspector General to assist the State in combating fraud, waste, and abuse in the State’s $45 billion Medicaid Program. MAXIMUS will assist the State in developing and implementing strategies to supplement its efforts to combat Medicaid fraud and abuse. The efforts are expected to improve the efficiency of New York’s Medicaid program and allow them to better serve their citizens.

Richard Montoni, CEO of MAXIMUS stated, "This is a very important project for MAXIMUS and the State of New York. Clearly, Medicaid fraud and abuse is a critical issue impacting State budgets nationwide. We are pleased to have the opportunity to extend our longstanding partnership with the State by supporting them in this major endeavor."

At $45 billion, the State of New York currently has the largest Medicaid budget in the country and provides healthcare for more than 4.2 million citizens each year. The State is dedicated to preventing fraud and waste, and has selected one of the top healthcare fraud prosecutors in the country, Jim Sheehan, to lead the newly formed Office of Medicaid Inspector General. By working with the State to develop an effective and comprehensive approach to fraud, waste, and abuse prevention in the Medicaid program, MAXIMUS expects to help recover funds on behalf of the State, as well as prevent future payments associated with fraud, waste, and abuse.

MAXIMUS is one of America’s leading government services companies devoted to providing program management, consulting, and information technology services. The Company has more than 5,200 employees located in more than 220 offices in the United States, Canada, and Australia.